A Case of Transformation of Primary Cutaneous Follicle Center Lymphoma to Diffuse Large B-Cell Lymphoma Involving the Parotid Gland and Cervical Lymph Nodes.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
29 Aug 2019
Historique:
entrez: 30 8 2019
pubmed: 30 8 2019
medline: 6 2 2020
Statut: epublish

Résumé

BACKGROUND Transformation of primary cutaneous follicle center lymphoma (PCFCL), a low-grade B-cell non-Hodgkin lymphoma (NHL), into a high-grade NHL is rare with uncertain prognosis and treatment. A case is reported of a 40-year-old man who presented with a scalp mass that was diagnosed histologically as PCFCL. Imaging of the head and neck identified diffuse large B-cell lymphoma (DLBCL) involving the parotid gland and cervical lymph nodes, which responded well to radiation therapy. CASE REPORT A 40-year-old African American man presented with a two-year history of a progressively enlarging scalp mass that measured 10.5×7.1×6.6 cm. Histology showed a low-grade lymphoma with a follicular pattern. Immunohistochemistry was positive for B-cell markers and Bcl-6, consistent with a diagnosis of PCFCL. Computed tomography (CT) identified a 4.9×3.7×3.4 cm mass in the left parotid gland with bilateral cervical lymphadenopathy that had been present for the previous two or three months. The diagnosis of DLBCL was made on histology from a needle biopsy. Treatment began with rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (R-EPOCH) chemotherapy, followed by radiation therapy to the scalp, both sides of the neck, and left parotid gland. At four-month follow-up, combined positron emission tomography (PET) and CT showed only diffuse low-level uptake in the scalp and parotid gland. CONCLUSIONS Transformation of low-grade PCFCL to high-grade DLBCL is rare, and the approach to treatment varies. This case showed a good response to chemotherapy and radiation therapy.

Identifiants

pubmed: 31462626
pii: 917389
doi: 10.12659/AJCR.917389
pmc: PMC6735615
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1273-1278

Références

Ann Oncol. 2003 Jan;14(1):131-9
pubmed: 12488305
J Clin Oncol. 2008 Nov 10;26(32):5165-9
pubmed: 18838711
Blood. 2009 May 21;113(21):5064-73
pubmed: 19279331
Case Rep Med. 2010;2010:296523
pubmed: 20589072
Chin Clin Oncol. 2015 Mar;4(1):10
pubmed: 25841717
Blood. 2015 Aug 13;126(7):851-7
pubmed: 26105149
Oncotarget. 2016 Jul 5;7(27):41242-41250
pubmed: 27183909
Lancet. 2017 Jul 15;390(10091):298-310
pubmed: 28153383
Indian J Dermatol. 2017 Mar-Apr;62(2):146-157
pubmed: 28400634
Pathology. 2018 Jan;50(1):74-87
pubmed: 29167021
Postepy Dermatol Alergol. 2017 Dec;34(6):625-628
pubmed: 29422831

Auteurs

Maurice L King (ML)

Department of Radiation Oncology, The University of Mississippi Medical Center, Jackson, MS, USA.

Toms Vengaloor Thomas (T)

Department of Radiation Oncology, The University of Mississippi Medical Center, Jackson, MS, USA.

Ashley A Albert (AA)

Department of Radiation Oncology, The University of Mississippi Medical Center, Jackson, MS, USA.

Sanjay Joseph (S)

Department of Radiation Oncology, The University of Mississippi Medical Center, Jackson, MS, USA.

Lakshmi Ramachandran Nair (L)

Department of Pathology and Clinical Laboratories, The University of Mississippi Medical Center, Jackson, MS, USA.

John T Lam (JT)

Department of Pathology and Clinical Laboratories, The University of Mississippi Medical Center, Jackson, MS, USA.

William C Woods (WC)

Department of Radiation Oncology, The University of Mississippi Medical Center, Jackson, MS, USA.

Mary Nittala (M)

Department of Radiation Oncology, The University of Mississippi Medical Center, Jackson, MS, USA.

Srinivasan Vijayakumar (S)

Department of Radiation Oncology, The University of Mississippi Medical Center, Jackson, MS, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH